Evidence map›Paper›PMID 41502238›Full record

SynthesisExpert reviews in molecular medicine2026

A Systematic Review of Autoimmunity in 22q11.2 Deletion Syndrome.

Hidayat Y Ogunsola, Sana Malik, Hannah Rogers, Brad D Pearce

Abstract readSystematic Review
In one paragraph

Synthesis in Expert reviews in molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hidayat Y OgunsolaRollins School of Public Health, https://ror.org/03czfpz43Emory University, Atlanta, USA.ORCID 0009-0006-4357-2211
Sana MalikSchool of Medicine, Medical Sciences and Nutrition, https://ror.org/016476m91University of Aberdeen, UK.ORCID 0009-0007-7440-5632
Hannah RogersLibrary (Head of Information Services), Woodruff Health Sciences Center, https://ror.org/03czfpz43Emory University, Atlanta, USA.
Brad D PearceEpidemiology, Rollins School of Public Health, https://ror.org/03czfpz43Emory University, Atlanta, USA.ORCID 0000-0002-3259-4275

Funding

NIH HHS 1-R21-MH083138-01A1
6 · The paper itself

Abstract

backgroundThe 22q11.2 Deletion Syndrome (22q11DS) is the most common chromosomal microdeletion disorder, characterised by a heterogeneous clinical spectrum including immunodeficiency, autoimmunity, and neuropsychiatric comorbidities. This systematic review critically appraises current evidence on autoimmunity in 22q11DS, fulfilling the need for an unbiased and comprehensive synthesis of the current literature.

methodsAn extensive search was conducted through PubMed, Web of Science, EMBASE, CINAHL, and the Cochrane Library using Boolean combinations of relevant keywords. Qualitative studies, abstracts, conference proceedings and non-English studies were excluded.

resultsA total of 82 peer-reviewed studies published since 1968 were identified. We identified a total of 40 distinct autoimmune conditions involving multiple organ systems. Haematological disorders were most frequently cited, followed by autoimmune thyroid diseases and systemic autoimmune diseases. Less common conditions included coeliac disease, psoriasis, vitiligo, alopecia areata, Raynaud's phenomenon, and vasculitis, while 19 diseases appeared only as single-case reports. Neuropsychiatric manifestations were addressed in 24 studies.

conclusionOur review confirms that autoimmunity is a complication of 22q11DS and highlights the need for epidemiological studies across organ-systems and inclusion of ethnically diverse populations. There was substantial variation in study designs, underscoring the need for more standardised approaches and larger sample sizes.

Indexed as

Autoimmune DiseasesAutoimmunityDiGeorge SyndromeHumans22q11.2DS22q.11DSautoimmuneautoimmune thyroid diseaseautoimmunityDiGeorgeDiGeorge syndromesystematic review

Identifiers

PMID41502238
PMCPMC13148428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.